Outcomes of Patients With Extramedullary Disease in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma From the Pooled LocoMMotion and MoMMent Studies
These results demonstrate the urgent need for more effective novel therapies for patients with EMD and highlight the need to use clear definitions of EMD and EMD response criteria for clinical trials.
Authors
- Vadim Strulev
- Katja Christina Weisel (ORCID: https://orcid.org/0000-0001-9422-6614)
- Ravi Vij (ORCID: https://orcid.org/0000-0001-8795-3610)
- Francesco Di Raimondo (ORCID: https://orcid.org/0000-0002-7749-0293)
- Marta Sonia González (ORCID: https://orcid.org/0000-0001-5494-9009)
- Suriya Kirkpatrick (ORCID: https://orcid.org/0000-0001-8291-1630)
- Philippe Moreau (ORCID: https://orcid.org/0000-0002-2868-7401)
- Britta Besemer
- Hartmut Goldschmidt (ORCID: https://orcid.org/0000-0003-0961-0035)
- Joanne Lindsey-Hill
- Emanuele Angelucci (ORCID: https://orcid.org/0000-0002-6512-6080)
- Jozefien Buyze (ORCID: https://orcid.org/0000-0001-6780-380X)
- Margaret Doyle
- Imène Haddad (ORCID: https://orcid.org/0009-0001-8742-0993)
- Lorenzo Acciarri (ORCID: https://orcid.org/0009-0002-2654-9459)
- Michel Delforge (ORCID: https://orcid.org/0000-0002-0147-2291)
- Mohamad Mohty (ORCID: https://orcid.org/0000-0001-8536-7781)
- Silva Koskinen
- María Esther González García
- Claire Albrecht
- Kathleen Gray
- María-Victoria Mateos
Institutions
- Johnson & Johnson (United States) (US)
- Nottingham University Hospitals NHS Trust (GB)
- Inserm (FR)
- Universität Hamburg (DE)
- University of the West of England (GB)
- Universidad de Salamanca (ES)
- Universidade de Santiago de Compostela (ES)
- Washington University in St. Louis (US)
- Heidelberg University (DE)
- Hotel Dieu Hospital (CA)
- University Hospital Heidelberg (DE)
- Centre Hospitalier Universitaire de Nantes (FR)
- Sorbonne Université (FR)
- Johnson & Johnson (Ireland) (IE)
- Johnson & Johnson (France) (FR)
- Complejo Hospitalario Universitario de Santiago (ES)
- Assistance Publique – Hôpitaux de Paris (FR)
- University Medical Center Hamburg-Eppendorf (DE)
- Policlinico Universitario di Catania (IT)
- Johnson & Johnson (Italy) (IT)
- Instituto de Investigación Biomédica de Salamanca (ES)
- Centre de Recherche Saint-Antoine (FR)
- Centro de Investigación del Cáncer (ES)
- Ospedale Policlinico San Martino (IT)
- Hospital Universitario De Cabueñes (ES)
- University of Tübingen (DE)
- KU Leuven (BE)
Publication Details
- Journal
- Clinical Lymphoma Myeloma & Leukemia
- Published
- 2025-03-30
- DOI
- https://doi.org/10.1016/j.clml.2025.03.014
- Citations
- 7
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 12.39
Funders
- Legend Biotech